Skip to search formSkip to main contentSkip to account menu

NP 184

Known as: NP-184, NP184 cpd 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
NP-184[2-(5-methyl-2-furyl) benzimidazole], a novel orally active antithrombotic agent with dual antiplatelet and anticoagulant activities
The established antiplatelet and anticoagulant agents show beneficial effects in the treatment of thromboembolic diseases… 
2010
2010
A novel compound, NP-184, inhibits the vascular endothelial growth factor induced angiogenesis.
2008
2008
NP-184, a Dual Thromboxane A2 Synthase Inhibitor and Thromboxane A2 Receptor Antagonist
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)